Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page
- Check2 days agoChange DetectedFooter now displays Revision: v3.3.4, replacing the previous v3.3.3; this update affects only version labeling and does not modify page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Locations section listing Guangdong as a study site and updated revision to v3.3.3; Guangdong Locations was removed as part of the update.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedPublications section now clarifies that listed publications are automatically filled from PubMed, and a revision note shows Revision: v3.3.1, replacing the previous wording (Revision: v3.2.0).SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding status notice was removed from the page. It previously warned that updates may not be up to date and directed users to opm.gov for updates.SummaryDifference0.4%

- Check74 days agoChange DetectedNew metadata entries were added indicating the last known status, the investigator Yanhong Deng from Sun Yat-sen University, the date by 2023-10, and verification status.SummaryDifference0.8%

Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.